Federal Contractor Profile
Medicines Company, The
$100M obligated·4 awards·2 agencies·2 NAICS
Federal Contracts
Showing award actions 1–7 of 7 funded award actions, most recent first.
- Contracts with positive obligations
- 4
- Funded award actions shown
- 7
- Obligations shown
- $100M
- Awarding agencies
- 2
This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.
Award data as of February 20, 2026. Source: USAspending federal award records.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Apr 22, 2024 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600026C | 541711 | THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF | $10M |
| Sep 29, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600026C | 541711 | THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF | $6.1M |
| Mar 31, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600026C | 541711 | THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF | $15M |
| Apr 22, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600026C | 541711 | THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF | $15M |
| Aug 13, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600026C | 541711 | THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF | $20M |
| Sep 15, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600026C | 541711 | THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF | $32M |
| Dec 4, 2015 | Department of Health and Human ServicesOFF ASST SEC ADM AND MGMT | HHSO100201400002C | 541711 | IGF::OT::IGFADVANCED DEVELOPMENT OF RPX7009 | $2.0M |
Get Alerted Before Medicines Company, The's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start for free